Journal Article10.1021/JM801331Y
The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists
300
TL;DR: This paper reviews hydrogenbond basicity scales in general and introduces the pKBHX scale with a brief thermodynamic discussion on the treatment of polyfunctional compounds and discusses the effects of a medium more polar than the definition solvent CCl4 and changes in the reference HB donor on the p KBHX Scale.
read more
Abstract: The hydrogen bond (HB) is one of the fundamental noncovalent interactions between a drug molecule and its local environment. For drug molecules, this local environment may be a biological target, a biological off-target, aqueous solution, a lipid membrane, or even a crystalline solid. Consequently, hydrogen bonding impacts a wide range of molecular properties critical to drug design including potency, selectivity, and permeability and solubility. Despite its importance, it is the authors’ experience that in general the medicinal chemistry community has a poor intuition for the relative basicity (i.e., strengths) of hydrogen-bond acceptors. In an attempt to assess the relative hydrogen-bond basicities of functional groups, it is common practice to resort to a simple correlation with pKBH, 8 which is generally incorrect and holds true only for closely related compounds in a series (i.e., a family dependent relationship). There is also a tendency to view hydrogen-bond acceptors as atomic sites and to consider them equivalent while disregarding the effects of organic functions and substituents that define the local molecular environment. This is evident in the lack of consideration for exploring hydrogen-bond basicity as an SAR parameter, as is commonly done to establish preferred steric, polar, basic, and acidic moieties. This poor intuition may partly stem from the lack of experimentally observable physical properties that are directly attributed to relative hydrogen-bondbasicities.Furthermore, despite thewell-known role of hydrogen bonds in protein-ligand interactions and the fact that hydrogen bonds are qualitatively well understood, it is generally admitted that quantitative data are needed. In the second section of this paper we review hydrogenbond basicity scales in general and introduce the pKBHX scale with a brief thermodynamic discussion on the treatment of polyfunctional compounds. In section 3 we discuss the effects of a medium more polar than the definition solvent CCl4 and changes in the reference HB donor on the pKBHX scale. In section 4, we present the pKBHX database and describe the fields of each entry,which correspond to threemain categories of data: HBA identification, thermodynamic, and spectroscopic. In section 5 we show that the pKBHX scale of HB basicity differs considerably from the pKBH scale of proton transfer basicity. This is important formedicinal chemistswho have a good knowledge of Broensted proton basicity scales and incorrectly consider HB basicity and proton basicity scales as equivalent. Section 6 reviews the hydrogen-bond basicities of functional groups relevant to medicinal chemistry while considering factors that modulate these values. Section 7 extends this medicinal chemistry discussion by providing examples of the role of hydrogen-bond basicity in properties of interest for drug design and briefly reviews computational approaches for addressing hydrogen bonding.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Applications of Fluorine in Medicinal Chemistry
TL;DR: The effects of the strategic incorporation of fluorine in drug molecules and applications in positron emission tomography are provided, as well as new synthetic methodologies that allow more facile access to a wide range of fluorinated compounds.
2.8K
Synopsis of some recent tactical application of bioisosteres in drug design.
TL;DR: In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compound optimization and the long-term success of drug candidates.
2.5K
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design.
TL;DR: In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a molecule are summarized.
1.8K
A Medicinal Chemist’s Guide to Molecular Interactions
TL;DR: This article compile and review the literature on molecular interactions as it pertains to medicinal chemistry through a combination of careful statistical analysis of the large body of publicly available X-ray structure data and experimental and theoretical studies of specific model systems.
1.4K
Organocatalysis: Opportunities and Challenges for Polymer Synthesis
TL;DR: In this article, the ring-opening polymerization of cyclic monomers is used as a representative polymerization process to illustrate some of the features of organic catalysts and initiators and compare them to metal-based approaches.
835
References
The Protein Data Bank
Helen M. Berman,John D. Westbrook,Zukang Feng,Gary L. Gilliland,Talapady N. Bhat,Helge Weissig,Ilya N. Shindyalov,Philip E. Bourne +7 more
TL;DR: The goals of the PDB are described, the systems in place for data deposition and access, how to obtain further information and plans for the future development of the resource are described.
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
TL;DR: Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described in this article, where the rule of 5 is used to predict poor absorption or permeability when there are more than 5 H-bond donors, 10 Hbond acceptors, and the calculated Log P (CLogP) is greater than 5 (or MlogP > 415).
16.8K
The Cambridge Structural Database: a quarter of a million crystal structures and rising
TL;DR: The Cambridge Structural Database now contains data for more than a quarter of a million small-molecule crystal structures, and projections concerning future accession rates indicate that the CSD will contain at least 500,000 crystal structures by the year 2010.
10.5K
Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid
James D. Watson,Francis Crick +1 more
TL;DR: The determination in 1953 of the structure of deoxyribonucleic acid (DNA), with its two entwined helices and paired organic bases, was a tour de force in X-ray crystallography and opened the way for a deeper understanding of perhaps the most important biological process.
10.3K